Physician profile
Hermann Peter Lorenz
NPI 1477697563
$2,616.95
in general payments reported to CMS, 2019-2025
6 companies · $1,900 in 2025
The $1,900 reported for 2025 was more than what 84% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.89 · 2021: $123 · 2022: $100 · 2023: $434 · 2024: $45.00 · 2025: $1,900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,900 · Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,900.00 |
| Food and Beverage | $479.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abeona Therapeutics, INC. | $1,900.00 | 2025 | Zevaskyn |
| Kls-Martin L.P. | $343.97 | 2019-2023 | |
| Depuy Synthes Sales INC. | $148.04 | 2023 | Na |
| Tela Bio, INC. | $138.67 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $45.00 | 2024 | Ethicon, Echelon Flex, Echelon Circular |
| Stryker Corporation | $41.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hermann Lorenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.